Submitted by Anonymous (not verified) on 6 February 2026 - 9:45
Human medicines European public assessment report (EPAR): Xerava, eravacycline, Date of authorisation: 20/09/2018, Revision: 10, Status: Authorised
Source:
Human medicines European public assessment report (EPAR): Xerava, eravacycline, Date of authorisation: 20/09/2018, Revision: 10, Status: Authorised